Bifogade filer
PDF
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Material |
| Industri | Plast, kemikalier & fetter |
The shareholders in aXichem AB (publ) are hereby convened to the annual general meeting on Wednesday 18 June 2025, at 10 a.m. at the company's offices at Södergatan 26, Malmö, Sweden.
Right to participate
Shareholders who wish to exercise their voting rights at the annual general meeting shall:
- be recorded in the share register maintained by Euroclear Sweden AB on Tuesday 10 June 2025, and
- notify the company of their participation by 12 p.m. on Thursday 12 June 2025.
Such notification shall be made by mail to aXichem AB (publ), Södergatan 26, 211 34 Malmö, Sweden stating "Annual General Meeting". Such notification may also be mabe by e-mail to post@axichem.se. The notification shall include the shareholder's name, personal identification number or corporate registration number (or similar), number of shares, address, daytime telephone number, and if any, and where applicable, details of representatives (not more than two) intended to accompany at the meeting.
Nominee-registered shares
In order to be entitled to participate in the general meeting, a shareholder who has had his/her shares nominee-registered must, in addition to registering for the general meeting, have the shares registered in his/her own name so that the shareholder is included in the share register on 10 June 2025. Such registration may be temporary (so called voting rights registration) and is requested from the nominee according to the nominee's procedures in such time in advance as determined by the nominee. Voting rights registrations that have been carried out by the relevant nominee at the latest by Thursday 12 June 2025 will be observed when producing the share register.
Proxy etc.
Shareholders represented by proxy must issue a written and duly signed power of attorney to the proxy. If a power of attorney is issued by a legal entity, a certificate of registration or its equivalent for the legal entity must be attached. Proxy forms are available on the company's website www.axichem.com and will be sent free of charge to shareholders who request them and provide their postal address. In order to facilitate registration at the general meeting, the power of attorney, certificates of registration and other authorising documents should be received by the company at the above address no later than Tuesday 17 June 2025.
Proposed agenda
- Opening of the general meeting
- Election of chairman of the general meeting
- Election of one or two persons to verify the minutes
- Preparation and approval of the voting list
- Approval of the agenda
- Determination as to whether the meeting has been duly convened
- Presentation of the annual report and the auditor's report as well as the consolidated accounts and the consolidated audit report
- Resolutions on:
- the adoption of the income statement and the balance sheet and the consolidated profit and loss account and consolidated balance sheet,
- allocation of the company's result according to the adopted balance sheet; and
- discharge from liability for the members of the board of directors and the managing director
- Determination of the number of board members and deputy board members and the number of auditors
- Determination of remuneration to the board of directors and the auditor
- Election of board members, chairman of the board and auditor
- Election of the nomination committee
- Resolution on authorization for the board of directors to issue new shares
- Closing of the general meeting
Proposals to resolutions
Election of chairman of the general meeting (item 2)
The nomination committee proposes that lawyer Thorbjörn Wennerholm, or in the event he is unable to attend, the person designated by the board of directors in his stead, be elected as the chairman of the meeting.
Allocation of the company's results (item 8b)
The board of directors and the managing director proposes that no dividend be paid and that the results for the 2024 financial year be carried forward to the next year's accounts.
Determination of the number of board members and deputy board members and the number of auditors (item 9)
The nomination committee proposes that the number of board members be six. No deputy board members are proposed. The nomination committee further proposes that the number of auditors be one, with no deputy auditor.
Determination of remuneration to the board of directors and the auditor (item 10)
The nomination committee proposes that the fee to the board of directors be set at eight price base amounts (Sw. Prisbasbelopp) for the chairman of the board and three price base amounts each for the other board members. Furthermore, it is proposed that remuneration to the auditor is paid according to approved bill.
Election of board members, chairman of the board and auditor (item 11)
The nomination committee proposes for the time until the end of the next annual general meeting the re-election of current board members Jan Gustavsson, Torsten Helsing, Jørn H. Berthelsen, Edward van den Elsen, Michael Engström and Christian Månsson. It is proposed that Jan Gustavsson be re-elected as chairman of the board.
The nomination committee also proposes, in accordance with the board's recommendation, the re-election of the registered audit firm Forvis Mazars AB. The audit firm has announced that the authorized public accountant Annika Larsson will serve as the auditor in charge.
Election of the nomination committee (item 12)
The nomination committee proposes that Anders Månsson (LMK Venture) and Torsten Helsing (Manakin LTD) be re-elected as members of the nomination committee in preparation for the 2026 annual general meeting, and that the nomination committee shall have the option to decide on appointing a third member, representing the company's other shareholders. Any such third member shall be appointed by the chairman of the board.
Authorization to issue shares (item 13)
The board of directors proposes that the general meeting resolve to authorize the board of directors, during the period until the next annual general meeting and on one or more occasions, with or without preferential rights for the shareholders, to resolve on the issue of new shares, convertibles, and/or warrants, provided that such issuance does not cause the company's share capital to exceed the maximum permitted share capital under the articles of association. Any such issuance resolution may also be made with provisions on non-cash consideration, set-off, or other conditions.
The purpose of the authorization is to increase the company's financial flexibility and the board of directors' scope of action, as well as potentially broaden the company's shareholder base.
The managing director is proposed to be authorized to make such minor adjustments to this resolution as may prove necessary in connection with registration at the Swedish Companies Registration Office and Euroclear Sweden AB.
Majority requirements
Resolutions under item 13 above requires, for its validity, that a minimum of two thirds of the votes cast and the shares represented at the general meeting support the resolution.
Miscellaneous
The annual report and other documentation regarding the resolutions will be presented by making them available on the company's website, www.axichem.com, and at the company's offices no later than three weeks before the general meeting. Copies of these documents will be sent to shareholders who request them and provide their postal address. The share register for the general meeting will also be available at the company. Shareholders are reminded of their right to request information pursuant to Chapter 7, Section 32 of the Swedish Companies Act.
Processing of personal data
For information on how your personal data is processed, please see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.
aXichem AB (publ) has corporate registration number 556739-8663 and its registered office in Lund.
______________________
Lund in May 2025
aXichem AB (publ)
The board of directors
The information was submitted, through the provision of the specified contact person, for publication on 16 May 2025, kl 07:30 AM CET.
Company contact:
Torsten Helsing, CEO, aXichem AB
Phone: +46 70 686 33 55. Email: torsten.helsing@axichem.se
About aXichem:
aXichem develops, patents and markets industrial chemicals. The company's first product is phenylcapsaicin, which is commercialized under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB. More information is available at www.axichem.com.